| タイトル | Cooperative cobinding of synthetic and natural ligands to the nuclear receptor PPAR gamma. |
|---|
| ジャーナル・号・ページ | Elife, Vol. 7, Year 2018 |
|---|
| 掲載日 | 2017年1月9日 (構造データの登録日) |
|---|
著者 | Shang, J. / Brust, R. / Mosure, S.A. / Bass, J. / Munoz-Tello, P. / Lin, H. / Hughes, T.S. / Tang, M. / Ge, Q. / Kamekencka, T.M. / Kojetin, D.J. |
|---|
リンク | Elife / PubMed:30575522 |
|---|
| 手法 | X線回折 |
|---|
| 解像度 | 1.95 - 2.73 Å |
|---|
| 構造データ | PDB-5ugm: Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Edaglitazone 手法: X-RAY DIFFRACTION / 解像度: 2.1 Å PDB-6aug: Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with SR16832 手法: X-RAY DIFFRACTION / 解像度: 2.73 Å PDB-6avi: Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with GW9662 and Nonanoic acid 手法: X-RAY DIFFRACTION / 解像度: 2.29 Å PDB-6mcz: Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Arachidonic Acid 手法: X-RAY DIFFRACTION / 解像度: 2.1 Å PDB-6md0: Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Oleic Acid 手法: X-RAY DIFFRACTION / 解像度: 1.95 Å PDB-6md1: Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with GW9662 and Oleic acid 手法: X-RAY DIFFRACTION / 解像度: 2.2 Å PDB-6md2: Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with GW9662 and Arachidonic acid 手法: X-RAY DIFFRACTION / 解像度: 2.2 Å PDB-6md4: Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Rosiglitazone and Oleic acid 手法: X-RAY DIFFRACTION / 解像度: 2.24 Å |
|---|
| 化合物 | ChemComp-8A7: (5R)-5-({4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-1-benzothiophen-7-yl}methyl)-1,3-thiazolidine-2,4-dione
ChemComp-BXG: 2-chloro-N-(6-methoxyquinolin-4-yl)-5-nitrobenzamide
ChemComp-BRL: 2,4-THIAZOLIDIINEDIONE, 5-[[4-[2-(METHYL-2-PYRIDINYLAMINO)ETHOXY]PHENYL]METHYL]-(9CL)
|
|---|
| 由来 | homo sapiens (ヒト)
|
|---|
キーワード | TRANSCRIPTION / Nuclear receptors / TZDs / Drug design / Therapeutic targets / transcription/transcription inhibitor / transcription-transcription inhibitor complex |
|---|